Introduction: Chronic pain is a costly and incapacitating condition, with a projected global prevalence of 20%. In South Africa, almost one in five adults experience chronic pain. The aim of this study was to assess the prevalence of chronic pain and the association between chronic pain intensity and the interference of pain with life domains in patients attending a primary health care center.
Methods: We conducted a cross-sectional quantitative study on a sample of 331 patients at Soshanguve Community Health Centre. The data were collected using the Wisconsin Brief Pain Questionnaire, a validated scale for measuring pain.
Results: The mean age of participants was 51.6 years (SD = ±15.15, range = 18-86). The median age was 48 years (interquartile range = 40-64). The prevalence of chronic pain was 21.5% (95% confidence interval [CI] 17.0-25.9). Approximately 58% of participants were female, and female patients were affected more frequently than male patients. Chronic pain was observed to be 11.1% more prevalent in females than in males. Chronic pain mildly impacted general activity in 33.8% of patients (95% CI 23.9-45.4), mood in 42.3% (95% CI 31.4-53.8), walking ability in 29.6% (95% CI 20.2-41.0), relationships in 47.9% (95% CI 36.7-59.3), sleep in 31.0% (95% CI 21.4-42.5), enjoyment of life in 39.4% (95% CI 28.9-51.1), and normal working ability in 25.3% (95% CI 16.7-36.6).
Conclusions: Findings from this study show that among patients who attended the primary health care clinic, chronic pain was highly prevalent and interfered with their life domains. The intensity of pain was high in a significant proportion of patients. These findings provide invaluable information needed for the improvement of resources at the primary care level to comprehensively evaluate pain in our communities.
简介慢性疼痛是一种代价高昂且使人丧失工作能力的疾病,预计全球发病率为 20%。在南非,几乎每五个成年人中就有一人患有慢性疼痛。本研究的目的是评估慢性疼痛的患病率以及慢性疼痛强度与疼痛对初级保健中心患者生活领域的干扰之间的关联:我们在 Soshanguve 社区医疗中心对 331 名患者样本进行了横断面定量研究。数据采用威斯康星州简短疼痛问卷收集,该问卷是一种经过验证的疼痛测量量表:参与者的平均年龄为 51.6 岁(SD = ±15.15,范围 = 18-86)。年龄中位数为 48 岁(四分位数间距 = 40-64)。慢性疼痛患病率为 21.5%(95% 置信区间 [CI] 17.0-25.9)。约 58% 的参与者为女性,女性患者的患病率高于男性患者。据观察,女性慢性疼痛的发病率比男性高出 11.1%。9%(95% CI 36.7-59.3)、睡眠31.0%(95% CI 21.4-42.5)、生活乐趣39.4%(95% CI 28.9-51.1)、正常工作能力25.3%(95% CI 16.7-36.6):研究结果表明,在初级保健诊所就诊的患者中,慢性疼痛的发病率很高,并干扰了他们的生活领域。相当一部分患者的疼痛强度很高。这些发现提供了宝贵的信息,有助于改善基层医疗机构的资源,全面评估我们社区的疼痛状况。
{"title":"Chronic pain: The prevalence of chronic pain in patients attending Soshanguve Community Health Centre.","authors":"Funeka Faith Pandelani, Suzan Louisa Nnanile Nyalunga, Thanyani Pandelani","doi":"10.1080/24740527.2023.2284152","DOIUrl":"10.1080/24740527.2023.2284152","url":null,"abstract":"<p><strong>Introduction: </strong>Chronic pain is a costly and incapacitating condition, with a projected global prevalence of 20%. In South Africa, almost one in five adults experience chronic pain. The aim of this study was to assess the prevalence of chronic pain and the association between chronic pain intensity and the interference of pain with life domains in patients attending a primary health care center.</p><p><strong>Methods: </strong>We conducted a cross-sectional quantitative study on a sample of 331 patients at Soshanguve Community Health Centre. The data were collected using the Wisconsin Brief Pain Questionnaire, a validated scale for measuring pain.</p><p><strong>Results: </strong>The mean age of participants was 51.6 years (SD = ±15.15, range = 18-86). The median age was 48 years (interquartile range = 40-64). The prevalence of chronic pain was 21.5% (95% confidence interval [CI] 17.0-25.9). Approximately 58% of participants were female, and female patients were affected more frequently than male patients. Chronic pain was observed to be 11.1% more prevalent in females than in males. Chronic pain mildly impacted general activity in 33.8% of patients (95% CI 23.9-45.4), mood in 42.3% (95% CI 31.4-53.8), walking ability in 29.6% (95% CI 20.2-41.0), relationships in 47.9% (95% CI 36.7-59.3), sleep in 31.0% (95% CI 21.4-42.5), enjoyment of life in 39.4% (95% CI 28.9-51.1), and normal working ability in 25.3% (95% CI 16.7-36.6).</p><p><strong>Conclusions: </strong>Findings from this study show that among patients who attended the primary health care clinic, chronic pain was highly prevalent and interfered with their life domains. The intensity of pain was high in a significant proportion of patients. These findings provide invaluable information needed for the improvement of resources at the primary care level to comprehensively evaluate pain in our communities.</p>","PeriodicalId":53214,"journal":{"name":"Canadian Journal of Pain-Revue Canadienne de la Douleur","volume":"8 1","pages":"2284152"},"PeriodicalIF":2.0,"publicationDate":"2023-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11195477/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141447593","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-11-10DOI: 10.1080/24740527.2023.2255070
Winfried Häuser, Mary-Ann Fitzcharles
{"title":"Adherence to Clinical Guidelines for Fibromyalgia: Help or Hindrance?","authors":"Winfried Häuser, Mary-Ann Fitzcharles","doi":"10.1080/24740527.2023.2255070","DOIUrl":"https://doi.org/10.1080/24740527.2023.2255070","url":null,"abstract":"","PeriodicalId":53214,"journal":{"name":"Canadian Journal of Pain-Revue Canadienne de la Douleur","volume":"60 4","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135092992","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-11-03DOI: 10.1080/24740527.2023.2272999
Caleb Tackey, P. Maxwell Slepian, Hance Clarke, Nimish Mittal
Post-viral pain syndrome, also known as post-viral syndrome (PVS), is a complex condition characterized by persistent pain, fatigue, musculoskeletal pain, neuropathic pain, neurocognitive difficulties, and sleep disturbances1,2 that can occur after an individual has recovered from a viral infection. Much remains unknown regarding the pathophysiology of post-viral syndromes and few studies have provided a comprehensive summary of the condition, agents that cause it, and successful treatment modalities. With the COVID-19 pandemic continuing to affect millions of people worldwide, the need for understanding the etiology of post-viral illness and how to help individuals cope with the sequalae is paramount.2 This narrative review provides a summary of the sequelae of post-viral syndromes, viral agents that cause it, the pathophysiology, treatment, and future considerations for research and targeted therapies.
{"title":"Post Viral Pain, Fatigue, and Sleep Disturbance Syndromes: Current knowledge and Future Directions","authors":"Caleb Tackey, P. Maxwell Slepian, Hance Clarke, Nimish Mittal","doi":"10.1080/24740527.2023.2272999","DOIUrl":"https://doi.org/10.1080/24740527.2023.2272999","url":null,"abstract":"Post-viral pain syndrome, also known as post-viral syndrome (PVS), is a complex condition characterized by persistent pain, fatigue, musculoskeletal pain, neuropathic pain, neurocognitive difficulties, and sleep disturbances1,2 that can occur after an individual has recovered from a viral infection. Much remains unknown regarding the pathophysiology of post-viral syndromes and few studies have provided a comprehensive summary of the condition, agents that cause it, and successful treatment modalities. With the COVID-19 pandemic continuing to affect millions of people worldwide, the need for understanding the etiology of post-viral illness and how to help individuals cope with the sequalae is paramount.2 This narrative review provides a summary of the sequelae of post-viral syndromes, viral agents that cause it, the pathophysiology, treatment, and future considerations for research and targeted therapies.","PeriodicalId":53214,"journal":{"name":"Canadian Journal of Pain-Revue Canadienne de la Douleur","volume":"46 10","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135818147","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-10-06DOI: 10.1080/24740527.2023.2266751
Rasheeda Darville-Beneby, Anna M. Lomanowska, Hai Chuan Yu, Parker Jobin, Brittany N. Rosenbloom, Gretchen Gabriel, Helena Daudt, Michael Negraeff, Tania Di Renna, Maria Hudspith, Hance Clarke
Background Recent studies show preoperative education can positively impact postoperative recovery, improving postoperative pain management and patient satisfaction. Gaps in preoperative education regarding postoperative pain and opioid use may lead to increased patient anxiety and persistent postoperative opioid use.
{"title":"The impact of preoperative patient education on postoperative pain, opioid use, and psychological outcomes: A narrative review","authors":"Rasheeda Darville-Beneby, Anna M. Lomanowska, Hai Chuan Yu, Parker Jobin, Brittany N. Rosenbloom, Gretchen Gabriel, Helena Daudt, Michael Negraeff, Tania Di Renna, Maria Hudspith, Hance Clarke","doi":"10.1080/24740527.2023.2266751","DOIUrl":"https://doi.org/10.1080/24740527.2023.2266751","url":null,"abstract":"Background Recent studies show preoperative education can positively impact postoperative recovery, improving postoperative pain management and patient satisfaction. Gaps in preoperative education regarding postoperative pain and opioid use may lead to increased patient anxiety and persistent postoperative opioid use.","PeriodicalId":53214,"journal":{"name":"Canadian Journal of Pain-Revue Canadienne de la Douleur","volume":"8 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135351965","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-10-06DOI: 10.1080/24740527.2023.2266738
Sherif M. Elsaraj, Mervyn Gornitsky, Richard Hovey, Firoozeh Samim, Zovinar Der Khatchadourian, Ana Velly
Insomnia and excessive daytime sleepiness, a surrogate marker of obstructive sleep apnea, are common sleep-related conditions among painful temporomandibular disorders (TMD) subjects. Obstructive sleep apnea was found to increase the risk of chronic painful TMD. This prospective cohort study aims to determine the contribution of insomnia and excessive daytime sleepiness (ESS/OSA) on acute to chronic painful TMD transition as well as its persistence when chronic pain is defined by: (i) duration (> 3 months), and (ii) dysfunction (Graded Chronic Pain Scale [GCPS II-IV]). From 456 subjects recruited between 2015 to 2021, through four locations in Canada, 378 completed the follow-up. A diagnosis was obtained using the Research Diagnostic Criteria or the Diagnostic Criteria for Temporomandibular Disorders. Insomnia was assessed with the Insomnia Severity Scale (ISS), and excessive daytime sleepiness was measured using the Epworth Sleepiness Scale (ESS/OSA), both at baseline. Subjects completed the GCPS form at baseline and 3-month follow-up. Borderline associations were found between ESS/OSA and the transition or persistence of chronic painful TMD when chronic pain was defined by pain duration (RR adjusted_duration = 1.11, P = 0.07) and dysfunction (RRadjusted_dysfunction =1.40, P = 0.051). Furthermore, ESS/OSA was specifically associated with persistent painful TMD when chronic pain was defined by pain duration (RR = 1.13, 95%CI: 1.00-1.26, P = 0.04). Insomnia was not related to the study outcomes (RRadjusted_duration = 0.94, P = 0.27, RRadjusted_dysfunction =1.00, P = 0.99). Results indicate that ESS/OSA contrary to insomnia predicted the persistence of chronic painful TMD at a 3-month follow-up.
失眠和白天过度嗜睡是阻塞性睡眠呼吸暂停的替代标志,是疼痛性颞下颌疾病(TMD)患者中常见的睡眠相关疾病。发现阻塞性睡眠呼吸暂停会增加慢性疼痛性TMD的风险。这项前瞻性队列研究旨在确定失眠和白天过度嗜睡(ESS/OSA)对急性到慢性疼痛性TMD转变的贡献,以及慢性疼痛的持久性,慢性疼痛的定义是:(i)持续时间(> 3个月),(ii)功能障碍(分级慢性疼痛量表[GCPS ii - iv])。2015年至2021年间,在加拿大的四个地点招募了456名受试者,其中378人完成了随访。使用研究诊断标准或颞下颌疾病诊断标准进行诊断。采用失眠严重程度量表(ISS)评估失眠症,使用Epworth嗜睡量表(ESS/OSA)测量白天过度嗜睡,两者均为基线。受试者在基线和3个月随访时完成GCPS表格。当慢性疼痛被定义为疼痛持续时间(RR adjusted_duration = 1.11, P = 0.07)和功能障碍(RRadjusted_dysfunction =1.40, P = 0.051)时,发现ESS/OSA与慢性疼痛性TMD的转变或持续存在边缘性关联。此外,当以疼痛持续时间定义慢性疼痛时,ESS/OSA与持续性疼痛性TMD特异性相关(RR = 1.13, 95%CI: 1.00-1.26, P = 0.04)。失眠与研究结果无关(RRadjusted_duration = 0.94, P = 0.27, RRadjusted_dysfunction =1.00, P = 0.99)。结果表明,在3个月的随访中,ESS/OSA与失眠相反,可预测慢性疼痛性TMD的持续存在。
{"title":"The contribution of insomnia and obstructive sleep apnea on the transition from acute to chronic painful temporomandibular disorders, and its persistence: a prospective 3-month cohort study","authors":"Sherif M. Elsaraj, Mervyn Gornitsky, Richard Hovey, Firoozeh Samim, Zovinar Der Khatchadourian, Ana Velly","doi":"10.1080/24740527.2023.2266738","DOIUrl":"https://doi.org/10.1080/24740527.2023.2266738","url":null,"abstract":"Insomnia and excessive daytime sleepiness, a surrogate marker of obstructive sleep apnea, are common sleep-related conditions among painful temporomandibular disorders (TMD) subjects. Obstructive sleep apnea was found to increase the risk of chronic painful TMD. This prospective cohort study aims to determine the contribution of insomnia and excessive daytime sleepiness (ESS/OSA) on acute to chronic painful TMD transition as well as its persistence when chronic pain is defined by: (i) duration (> 3 months), and (ii) dysfunction (Graded Chronic Pain Scale [GCPS II-IV]). From 456 subjects recruited between 2015 to 2021, through four locations in Canada, 378 completed the follow-up. A diagnosis was obtained using the Research Diagnostic Criteria or the Diagnostic Criteria for Temporomandibular Disorders. Insomnia was assessed with the Insomnia Severity Scale (ISS), and excessive daytime sleepiness was measured using the Epworth Sleepiness Scale (ESS/OSA), both at baseline. Subjects completed the GCPS form at baseline and 3-month follow-up. Borderline associations were found between ESS/OSA and the transition or persistence of chronic painful TMD when chronic pain was defined by pain duration (RR adjusted_duration = 1.11, P = 0.07) and dysfunction (RRadjusted_dysfunction =1.40, P = 0.051). Furthermore, ESS/OSA was specifically associated with persistent painful TMD when chronic pain was defined by pain duration (RR = 1.13, 95%CI: 1.00-1.26, P = 0.04). Insomnia was not related to the study outcomes (RRadjusted_duration = 0.94, P = 0.27, RRadjusted_dysfunction =1.00, P = 0.99). Results indicate that ESS/OSA contrary to insomnia predicted the persistence of chronic painful TMD at a 3-month follow-up.","PeriodicalId":53214,"journal":{"name":"Canadian Journal of Pain-Revue Canadienne de la Douleur","volume":"38 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135351520","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-09-29DOI: 10.1080/24740527.2023.2264895
Jessica Parnell, Newton Martin, Annemarie Dedek, Christopher Rudyk, Jeffrey Landrigan, Justin Bellavance, Simon Vanderloo, Eve C. Tsai, Michael E. Hildebrand
Background Preclinical and clinical evidence suggests that cannabis has potential analgesic properties. However, cannabinoid receptor expression and localization within spinal cord pain processing circuits remains to be characterized across sex and species.
{"title":"Cannabinoid CB1 receptor expression and localization in the dorsal horn of male and female rat and human spinal cord","authors":"Jessica Parnell, Newton Martin, Annemarie Dedek, Christopher Rudyk, Jeffrey Landrigan, Justin Bellavance, Simon Vanderloo, Eve C. Tsai, Michael E. Hildebrand","doi":"10.1080/24740527.2023.2264895","DOIUrl":"https://doi.org/10.1080/24740527.2023.2264895","url":null,"abstract":"Background Preclinical and clinical evidence suggests that cannabis has potential analgesic properties. However, cannabinoid receptor expression and localization within spinal cord pain processing circuits remains to be characterized across sex and species.","PeriodicalId":53214,"journal":{"name":"Canadian Journal of Pain-Revue Canadienne de la Douleur","volume":"69 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135200039","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-09-13DOI: 10.1080/24740527.2023.2258537
Lise Dassieu, Emilie Paul-Savoie, Élise Develay, Ana Cecilia Villela Guilhon, Line Guénette, Kadija Perreault, Hélène Beaudry, Laurent Dupuis, Claudie Audet, Anaïs Lacasse
Background The use of cannabis to treat chronic pain is under debate despite high expectations from patients. Qualitative data exploring both patients’ and health professionals’ perspectives are scarce.Aims This study aimed to understand the experiences and perceptions of people living with chronic pain and community pharmacists regarding the role of cannabis in chronic pain treatment, in the Canadian context where both medical and recreational cannabis are legal.Methods We conducted 12 online focus groups (July 2020-Februrary 2021), with 26 patients and 19 community pharmacists using semi-structured discussion guides. All discussions were audio-recorded and transcribed verbatim were analyzed using a reflexive thematic approach.Results We developed three themes related to patients’ perspectives and three themes related to pharmacists’ perspectives. Patients’ perspectives: (1) Cannabis as an alternative to other pain medications; (2) A new treatment with potential health-related risks; (3) A therapy rather than a recreational drug. Pharmacists’ perspectives: (1) Challenges in monitoring drug interactions with cannabis in the context of scarce research data; (2) Informing and treating patients self-medicating with cannabis amid its growing popularity; (3) Financial costs and legal constraints for patients.Conclusions This study highlights patients’ and pharmacists’ urgent need for reliable information regarding the benefits and risks of cannabis. Training tailored to pharmacists’ needs and evidence-based information for patients should be developed to support pharmacists’ practice, improve patients’ experience and promote safe cannabis use.
{"title":"Experiences and perceptions of medical cannabis among people living with chronic pain and community pharmacists: a qualitative study in Canada","authors":"Lise Dassieu, Emilie Paul-Savoie, Élise Develay, Ana Cecilia Villela Guilhon, Line Guénette, Kadija Perreault, Hélène Beaudry, Laurent Dupuis, Claudie Audet, Anaïs Lacasse","doi":"10.1080/24740527.2023.2258537","DOIUrl":"https://doi.org/10.1080/24740527.2023.2258537","url":null,"abstract":"Background The use of cannabis to treat chronic pain is under debate despite high expectations from patients. Qualitative data exploring both patients’ and health professionals’ perspectives are scarce.Aims This study aimed to understand the experiences and perceptions of people living with chronic pain and community pharmacists regarding the role of cannabis in chronic pain treatment, in the Canadian context where both medical and recreational cannabis are legal.Methods We conducted 12 online focus groups (July 2020-Februrary 2021), with 26 patients and 19 community pharmacists using semi-structured discussion guides. All discussions were audio-recorded and transcribed verbatim were analyzed using a reflexive thematic approach.Results We developed three themes related to patients’ perspectives and three themes related to pharmacists’ perspectives. Patients’ perspectives: (1) Cannabis as an alternative to other pain medications; (2) A new treatment with potential health-related risks; (3) A therapy rather than a recreational drug. Pharmacists’ perspectives: (1) Challenges in monitoring drug interactions with cannabis in the context of scarce research data; (2) Informing and treating patients self-medicating with cannabis amid its growing popularity; (3) Financial costs and legal constraints for patients.Conclusions This study highlights patients’ and pharmacists’ urgent need for reliable information regarding the benefits and risks of cannabis. Training tailored to pharmacists’ needs and evidence-based information for patients should be developed to support pharmacists’ practice, improve patients’ experience and promote safe cannabis use.","PeriodicalId":53214,"journal":{"name":"Canadian Journal of Pain-Revue Canadienne de la Douleur","volume":"225 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135734072","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-08-22eCollection Date: 2023-01-01DOI: 10.1080/24740527.2023.2249054
Quinn Tate, Guilherme Ferreira-Dos-Santos, Darrell Vydra, Nuno Ferreira-Silva, Sahil Gupta, Mark Friedrich B Hurdle
Chronic pain following distal biceps rupture (DBR) is often nonspecific in that it may arise due to the injury, subsequent surgical repair, or a combination of factors, making the painful symptoms challenging to treat. Peripheral nerve injury in the setting of DBR most commonly affects the musculocutaneous nerve or one of its terminal branches and may lead to chronic neuropathic pain involving the elbow and lateral/radial aspect of the forearm. In this brief technical report, we describe an ultrasound-guided (USG) technique for percutaneous implantation of a peripheral nerve stimulator (PNS) targeting the musculocutaneous nerve, along with an illustrative case report of successful treatment of chronic refractory pain following DBR utilizing this technique. Six months postimplantation, the patient reported a greater than 60% baseline pain intensity reduction, and no complications were noted.
{"title":"Ultrasound-Guided Percutaneous Peripheral Nerve Stimulation of the Musculocutaneous Nerve for Refractory Antecubital ElbowPain-Brief Technical Report and Illustrative Case Report.","authors":"Quinn Tate, Guilherme Ferreira-Dos-Santos, Darrell Vydra, Nuno Ferreira-Silva, Sahil Gupta, Mark Friedrich B Hurdle","doi":"10.1080/24740527.2023.2249054","DOIUrl":"https://doi.org/10.1080/24740527.2023.2249054","url":null,"abstract":"<p><p>Chronic pain following distal biceps rupture (DBR) is often nonspecific in that it may arise due to the injury, subsequent surgical repair, or a combination of factors, making the painful symptoms challenging to treat. Peripheral nerve injury in the setting of DBR most commonly affects the musculocutaneous nerve or one of its terminal branches and may lead to chronic neuropathic pain involving the elbow and lateral/radial aspect of the forearm. In this brief technical report, we describe an ultrasound-guided (USG) technique for percutaneous implantation of a peripheral nerve stimulator (PNS) targeting the musculocutaneous nerve, along with an illustrative case report of successful treatment of chronic refractory pain following DBR utilizing this technique. Six months postimplantation, the patient reported a greater than 60% baseline pain intensity reduction, and no complications were noted.</p>","PeriodicalId":53214,"journal":{"name":"Canadian Journal of Pain-Revue Canadienne de la Douleur","volume":"7 1","pages":"2249054"},"PeriodicalIF":2.4,"publicationDate":"2023-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10524777/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41123456","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-07-28eCollection Date: 2023-01-01DOI: 10.1080/24740527.2023.2229400
B J Byiers, A M Merbler, A Raiter, C C Burkitt, F J Symons
Background: Although delayed or decreased responses to pain are commonly reported among caregivers of individuals with Rett syndrome (RTT), previous studies in relatively small samples have documented that caregivers are concerned about pain, particularly due to gastrointestinal and musculoskeletal conditions.
Aims: The purpose of the current study was to investigate in detail caregivers' perceptions of pain sensitivity, as well as the types, severity, and effect of pain experienced by individuals with RTT in a larger sample than previous studies.
Methods: A total of 51 caregivers (mostly mothers) participated in the study, which involved standardized questionnaires and interviews. The individuals with RTT ranged in age from 2 to 52 years of age, and most (n = 46; 90%) met criteria for classic RTT.
Results: Across the sample, 84% of caregivers reported that they believed that their child was less sensitive to pain compared to her typically developing peers. Despite this perception, 63% of caregivers reported that their child had experienced at least one form of pain in the previous 7 days, and 57% reported their child experienced at least one form of chronic pain. On average, caregivers reported that their child's pain was of moderate severity and interfered with at least one activity of daily living.
Conclusions: The results suggest that pain is a substantial concern among caregivers of individuals with RTT and indicate that additional research is needed to understand the apparent paradox of frequently reported pain experiences despite widespread perceptions of decreased pain sensitivity.
{"title":"Caregiver Perspectives on Pain Sensitivity and Pain Experience in Rett Syndrome.","authors":"B J Byiers, A M Merbler, A Raiter, C C Burkitt, F J Symons","doi":"10.1080/24740527.2023.2229400","DOIUrl":"10.1080/24740527.2023.2229400","url":null,"abstract":"<p><strong>Background: </strong>Although delayed or decreased responses to pain are commonly reported among caregivers of individuals with Rett syndrome (RTT), previous studies in relatively small samples have documented that caregivers are concerned about pain, particularly due to gastrointestinal and musculoskeletal conditions.</p><p><strong>Aims: </strong>The purpose of the current study was to investigate in detail caregivers' perceptions of pain sensitivity, as well as the types, severity, and effect of pain experienced by individuals with RTT in a larger sample than previous studies.</p><p><strong>Methods: </strong>A total of 51 caregivers (mostly mothers) participated in the study, which involved standardized questionnaires and interviews. The individuals with RTT ranged in age from 2 to 52 years of age, and most (<i>n</i> = 46; 90%) met criteria for classic RTT.</p><p><strong>Results: </strong>Across the sample, 84% of caregivers reported that they believed that their child was less sensitive to pain compared to her typically developing peers. Despite this perception, 63% of caregivers reported that their child had experienced at least one form of pain in the previous 7 days, and 57% reported their child experienced at least one form of chronic pain. On average, caregivers reported that their child's pain was of moderate severity and interfered with at least one activity of daily living.</p><p><strong>Conclusions: </strong>The results suggest that pain is a substantial concern among caregivers of individuals with RTT and indicate that additional research is needed to understand the apparent paradox of frequently reported pain experiences despite widespread perceptions of decreased pain sensitivity.</p>","PeriodicalId":53214,"journal":{"name":"Canadian Journal of Pain-Revue Canadienne de la Douleur","volume":"7 1","pages":"2229400"},"PeriodicalIF":2.0,"publicationDate":"2023-07-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10392763/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10196196","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Introduction: Approximately 15% to 40% of persons with chronic pain as a primary disorder experience brain fog. Prior research has investigated the etiology of "brain fog" in conditions in which pain presents as a key feature (e.g., fibromyalgia). However, it remains understudied in the context of chronic 10 musculoskeletal pain. Following current scoping review guidelines, we obtained stakeholder input from patient and health care professionals (HCPs) to define this phenomenon. Specific aims of this review were to (1) identify factors contributing to brain fog, (2) identify the functional correlates of brain fog and assessments used to measure them, and (3) establish a definition of brain fog that can be employed by researchers and HCPs to advance research and care.
Methods: A scoping review was conducted using recommendations of the Joanna Briggs Institute methodology of scoping reviews and the Levac et al methodology. Embase, Cinahl, PsycINFO, and Medline was searched to identify relevant sources. Findings were verified with patient and healthcare professionals.
Results: We identified four 15 key features of brain fog: perceived variability, subjective cognitive dysfunction, participation limitations, and changes in functional activities. We developed a model of brain fog illustrating the overlapping categories of contributors to brain fog in chronic musculoskeletal pain: (1) neuroanatomical and neurophysiological, (2) mental health/emotional, and (3) environmental/lifestyle.
Conclusion: The results of this scoping review conclude that the inconsistency in research regarding brain fog in 20 chronic musculoskeletal pain is obstructing a clear understanding of the phenomenon and therefore may be impeding persons with chronic pain and brain fog from receiving optimal care.
{"title":"Understanding the Experience and Impacts of Brain Fog in Chronic Pain: A Scoping Review.","authors":"Ronessa Dass, Mohini Kalia, Jocelyn Harris, Tara Packham","doi":"10.1080/24740527.2023.2217865","DOIUrl":"10.1080/24740527.2023.2217865","url":null,"abstract":"<p><strong>Introduction: </strong>Approximately 15% to 40% of persons with chronic pain as a primary disorder experience brain fog. Prior research has investigated the etiology of \"brain fog\" in conditions in which pain presents as a key feature (e.g., fibromyalgia). However, it remains understudied in the context of chronic 10 musculoskeletal pain. Following current scoping review guidelines, we obtained stakeholder input from patient and health care professionals (HCPs) to define this phenomenon. Specific aims of this review were to (1) identify factors contributing to brain fog, (2) identify the functional correlates of brain fog and assessments used to measure them, and (3) establish a definition of brain fog that can be employed by researchers and HCPs to advance research and care.</p><p><strong>Methods: </strong>A scoping review was conducted using recommendations of the Joanna Briggs Institute methodology of scoping reviews and the Levac et al methodology. Embase, Cinahl, PsycINFO, and Medline was searched to identify relevant sources. Findings were verified with patient and healthcare professionals.</p><p><strong>Results: </strong>We identified four 15 key features of brain fog: perceived variability, subjective cognitive dysfunction, participation limitations, and changes in functional activities. We developed a model of brain fog illustrating the overlapping categories of contributors to brain fog in chronic musculoskeletal pain: (1) neuroanatomical and neurophysiological, (2) mental health/emotional, and (3) environmental/lifestyle.</p><p><strong>Conclusion: </strong>The results of this scoping review conclude that the inconsistency in research regarding brain fog in 20 chronic musculoskeletal pain is obstructing a clear understanding of the phenomenon and therefore may be impeding persons with chronic pain and brain fog from receiving optimal care.</p>","PeriodicalId":53214,"journal":{"name":"Canadian Journal of Pain-Revue Canadienne de la Douleur","volume":"7 1","pages":"2217865"},"PeriodicalIF":2.0,"publicationDate":"2023-07-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10334862/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10185496","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}